RESUMO
Adoptive immunotherapy with ex vivo-expanded antigen-specific cytotoxic T lymphocytes (CTLs) has been shown to clear viral infections and eliminate tumors in murine models. Clinical trials have also reported promising data for the use of adoptive immunotherapy to treat cytomegalovirus (CMV) and Epstein-Barr viral (EBV) infections in bone marrow transplant recipients. For these indications, the need for ex vivo-expanded CTLs is often short lived, until the immune system is reconstituted by the donor transplant. In chronic disease settings, increased longevity of adoptively transferred CTLs and generation of memory will be necessary. The additional administration of helper functions normally supplied by antigen-specific T helper (Th) cells will probably be essential for long-term survival of adoptively transferred CTLs. Toward this goal of supplying helper functions, we transduced human CTLs with chimeric GM-CSFR/IL-2R receptors that deliver an IL-2 signal on binding GM-CSF. Clones expressing the chimeric receptors proliferated in response to GM-CSF. Stimulation with antigen induced GM-CSF production and resulted in an autocrine growth loop such that the CTL clones proliferated in the absence of exogenous cytokines. This type of genetic modification has potential for increasing the circulating half-life and, by extension, the efficacy of ex vivo-expanded CTLs.
Assuntos
Receptores de Fator Estimulador das Colônias de Granulócitos e Macrófagos/genética , Receptores de Interleucina-2/genética , Proteínas Recombinantes de Fusão/genética , Retroviridae/genética , Linfócitos T Citotóxicos/metabolismo , Transdução Genética , Animais , Citometria de Fluxo , Vetores Genéticos , Fator Estimulador de Colônias de Granulócitos e Macrófagos/metabolismo , Humanos , Imunoterapia Adotiva , Ativação Linfocitária , Camundongos , Receptores de Fator Estimulador das Colônias de Granulócitos e Macrófagos/metabolismo , Receptores de Interleucina-2/metabolismo , Proteínas Recombinantes de Fusão/metabolismo , Linfócitos T Citotóxicos/virologiaRESUMO
The introduction and expression of genes in somatic cells is an innovative therapy for correcting genetic deficiency diseases and augmenting immune function. A potential obstacle to gene therapy is the elimination of such gene-modified cells by an immune response to novel protein products of the introduced genes. We are conducting an immunotherapy trial in which individuals seropositive for human immunodeficiency virus (HIV) receive CD8+ HIV-specific cytotoxic T cells modified by retroviral transduction to express a gene permitting positive and negative selection. However, five of six subjects developed cytotoxic T-lymphocyte responses specific for the novel protein and eliminated the transduced cytotoxic T cells. The rejection of genetically modified cells by these immunocompromised hosts suggests that strategies to render gene-modified cells less susceptible to host immune surveillance will be required for successful gene therapy of immunocompetent hosts.
Assuntos
Linfócitos T CD8-Positivos/imunologia , Citotoxicidade Imunológica , Antígenos HIV/imunologia , Infecções por HIV/terapia , Imunoterapia Adotiva , Apresentação de Antígeno , Sequência de Bases , Linfócitos T CD8-Positivos/transplante , Infecções por HIV/imunologia , Antígenos de Histocompatibilidade Classe I/imunologia , Humanos , Dados de Sequência MolecularRESUMO
Transduction of the murine interferon-alpha (IFN-alpha) gene into various malignant mouse tumor cells has resulted in the loss of tumorigenicity and an acquired capacity to induce long-lasting antitumor immunity following their injection into immunocompetent syngeneic mice. In the present study, we investigated the effectiveness of IFN-alpha-producing tumor cells in the therapy of mice with established mouse tumors. In DBA/2 mice bearing subcutaneous (s.c.) Friend erythroleukemia cell (FLC) tumors, we found that to achieve some antitumor response (i) it was necessary to inject high numbers of IFN-alpha-producing FLC, which occasionally lead to the formation of slowly growing tumors; and, that (ii) repeated injections of irradiated IFN-alpha-FLC did not result in any antitumor effect. The therapeutic potential of IFN-alpha-producing FLC rendered sensitive to ganciclovir (GCV), by transfer of the herpes simplex virus thymidine kinase (tk) gene, was investigated. Complete tumor rejection and cure was observed in > or = 70% of the animals after injection of high numbers (10(7)) of IFN-alpha-producing tk-expressing tumor cells followed 4 days later by repeated GCV treatments, whereas only a slight increase in survival time was obtained after administration of control tk-expressing tumor cells (not producing IFN) and GCV. Tumor rejection was associated with a dramatic destruction of tumor tissue and with the subsequent development of a potent and long-lasting antitumor immunity. No therapeutic effect was observed in immunosuppressed nude mice. These data indicate that this approach may represent an effective and safe therapeutic strategy for antitumor cytokine gene therapy.
Assuntos
Vírus da Leucemia Murina de Friend , Ganciclovir/farmacologia , Interferon-alfa/genética , Leucemia Eritroblástica Aguda/terapia , Simplexvirus/enzimologia , Timidina Quinase/genética , Animais , Linhagem Celular , Células Clonais , Expressão Gênica , Sistema Imunitário , Interferon-alfa/metabolismo , Leucemia Eritroblástica Aguda/patologia , Masculino , Camundongos , Camundongos Endogâmicos DBA , Camundongos Nus , Metástase Neoplásica , Simplexvirus/genética , Timidina Quinase/metabolismo , Transfecção , Células Tumorais CultivadasRESUMO
The herpes simplex virus thymidine kinase (HSV-TK) converts ganciclovir (GCV) into a toxic product and allows selective elimination of TK+ cells in vitro and in vivo. It is currently being used in clinical gene therapy trials as a therapeutic gene or as a safety marker. We have analyzed the susceptibility of different tumor cell lines to the TK/GCV-mediated "suicide" effect. Therefore, tumor cells TSA, J558L, EB, and ESB and, as a control, NIH-3T3 cells were infected with a retrovirus containing a hygromycin/TK fusion gene. All cell lines were sensitive to GCV in vitro; however, the concentration of GCV and the time needed to eliminate tumor cells completely considerably varied between different tumor cell lines. TSA-TK cells were completely eliminated within 10 days in 1 microg/ml GCV, whereas ESB-TK cells required 22 days in 10 microg/ml GCV. When two cell lines were examined, the differing sensitivity to GCV in vitro correlated with the ability to eradicate TK+ tumors in vivo. TSA-TK tumors could be eliminated in almost all animals by systemic GCV administration, whereas ESB-TK tumors were completely resistant. Different sensitivity to GCV was not due to different TK expression levels because the cells were similarly resistant to hygromycin, and Western blot analysis with an anti-TK antiserum revealed similar protein amounts in TSA/TK and ESB-TK cells. Together, the results demonstrate that tumor cells are highly different concerning the susceptibility to the TK/GCV effect, which, however, may be tested for in vitro.
Assuntos
Antimetabólitos Antineoplásicos/farmacologia , Ganciclovir/farmacologia , Simplexvirus/enzimologia , Timidina Quinase/metabolismo , Células 3T3 , Animais , Antimetabólitos Antineoplásicos/farmacocinética , Biotransformação , Relação Dose-Resposta a Droga , Ensaios de Seleção de Medicamentos Antitumorais , Feminino , Ganciclovir/farmacocinética , Terapia Genética , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos DBA , Timidina Quinase/genética , Fatores de Tempo , Células Tumorais CultivadasRESUMO
We have constructed a panel of human x murine microcell hybrids containing individual human chromosomes tagged with a dual selectable marker conferring hygromycin B resistance and ganciclovir sensitivity. Over 500 independent microcell hybrids (B78MC) were generated and more than 200 individually isolated. We have identified the human chromosome content of several B78MC hybrids and verified that the majority are responsive to positive and negative selection. Once fully characterized, this panel will be useful in the study of dominant regulators of gene activity, such as tissue specific regulators and tumor suppressor genes.
Assuntos
Cromossomos Humanos , Cinamatos , Células Híbridas , Animais , Linhagem Celular , Técnicas de Cultura/métodos , Fibroblastos/citologia , Ganciclovir/toxicidade , Marcadores Genéticos , Herpesvirus Humano 1/genética , Humanos , Higromicina B/análogos & derivados , Higromicina B/farmacologia , Hibridização in Situ Fluorescente , Masculino , Melanoma Experimental , Camundongos , Fosfotransferases (Aceptor do Grupo Álcool)/genética , Sitios de Sequências Rotuladas , Pele/citologia , Timidina Quinase/genéticaRESUMO
Retrovirus-mediated gene transfer into human hematopoietic stem cells has been proposed as a means of therapy for various inherited diseases and as a method of gene marking. The transduction efficiency of an amphotropic retroviral vector (PA317/HyTK) containing a hygromycin phosphotransferase-thymidine kinase fusion gene was examined with human CD34+ bone marrow cells in the presence of interleukin-3 (IL-3), interleukin-6 (IL-6), and stem cell factor. Transduction efficiencies determined from the ability of transduced granulocyte-macrophage colony forming units (CFU-GM) to grow in hygromycin B and from polymerase chain reaction analysis of individual transduced CFU-GM growing in the presence of hygromycin B were 0.3-3.0% (mean +/- S.D., 1.1 +/- 0.9%) and 0.1-1.2% (mean +/- S.D., 0.5 +/- 0.4%), respectively. Ganciclovir at a dose of approximately 1 microM reduced the number of CFU-GM derived from vector-infected CD34+ cells by 50%. These findings demonstrate that human hematopoietic stem cells infected with this retroviral vector are susceptible to ganciclovir, offering the potential to control transduced gene expression in vivo.
Assuntos
Antígenos CD , Células da Medula Óssea , Clonagem Molecular , Técnicas de Transferência de Genes , Vetores Genéticos , Fosfotransferases (Aceptor do Grupo Álcool)/genética , Retroviridae , Timidina Quinase/genética , Antígenos CD34 , Ganciclovir/farmacologia , Células-Tronco Hematopoéticas/citologia , Humanos , Transdução GenéticaRESUMO
Although the proliferation of CD8+ CTL typically requires cytokine support provided by helper T cells, a subset of naturally occurring CD8+ CTL are capable of proliferating independently of T cell help. Such helper-independent CTL have previously been shown to possess IL-1 receptors (IL-1R) and to proliferate in response to IL-1 through endogenous production of IL-2. In this study, we have transduced conventional helper-dependent CTL clones with a retroviral vector encoding the murine type I IL-1R. Transduced CTL selected in G418 expressed vector-derived transcripts encoding IL-1R and displayed approximately 1000 cell surface receptors with an IL-1 affinity typical for the type I IL-1R. In contrast to parental cells, transduced CTL proliferated in response to IL-1 in the presence of Ag, without a requirement for helper T cells, IL-2, or other cytokine support. Stimulation with both IL-1 and Ag was necessary for the proliferative response. No endogenous synthesis of IL-2 could be detected in the IL-1R transduced cells in response to IL-1 stimulation, in the presence or absence of Ag. The IL-1R-induced phenotype was demonstrated in two independent T cell clones, both of which retained Ag-specific cytolytic activity. No such conversion to a helper-independent phenotype was induced by a retroviral vector encoding only the neo gene. The behavior of the IL-1R-transduced CTL in proliferation assays thus resembled that of the naturally occurring helper-independent CTL.
Assuntos
Ativação Linfocitária , Receptores de Interleucina-1/genética , Subpopulações de Linfócitos T/imunologia , Linfócitos T Citotóxicos/imunologia , Linfócitos T Auxiliares-Indutores/imunologia , Animais , Antígenos CD8/análise , Células Clonais , Citotoxicidade Imunológica , Expressão Gênica , Técnicas In Vitro , Interleucina-2/biossíntese , Interleucina-4/biossíntese , Camundongos , RNA Mensageiro/genética , Retroviridae , TransfecçãoAssuntos
Transplante de Medula Óssea , Soropositividade para HIV/terapia , Imunoterapia Adotiva , Linfoma Relacionado a AIDS/terapia , Linfócitos T Citotóxicos/transplante , Adolescente , Adulto , Antígenos CD8 , Protocolos Clínicos , Terapia Combinada , Soropositividade para HIV/complicações , Soropositividade para HIV/tratamento farmacológico , Humanos , Linfoma Relacionado a AIDS/etiologia , Linfoma Relacionado a AIDS/cirurgia , Pessoa de Meia-Idade , Linfócitos T Citotóxicos/imunologia , Zidovudina/uso terapêuticoRESUMO
cDNA clones corresponding to an Mr approximately 80,000 receptor (type I receptor) for interleukin-1 (IL-1) have been isolated previously by mammalian expression. Here, we report the use of an improved expression cloning method to isolate human and murine cDNA clones encoding a second type (Mr approximately 60,000) of IL-1 receptor (type II receptor). The mature type II IL-1 receptor consists of (i) a ligand binding portion comprised of three immunoglobulin-like domains; (ii) a single transmembrane region; and (iii) a short cytoplasmic domain of 29 amino acids. This last contrasts with the approximately 215 amino acid cytoplasmic domain of the type I receptor, and suggests that the two IL-1 receptors may interact with different signal transduction pathways. The type II receptor is expressed in a number of different tissues, including both B and T lymphocytes, and can be induced in several cell types by treatment with phorbol ester. Both IL-1 receptors appear to be well conserved in evolution, and map to the same chromosomal location. Like the type I receptor, the human type II IL-1 receptor can bind all three forms of IL-1 (IL-1 alpha, IL-1 beta and IL-1ra). Vaccinia virus contains an open reading frame bearing strong resemblance to the type II IL-1 receptor.
Assuntos
Linfócitos B/metabolismo , Interleucina-1/metabolismo , Receptores Imunológicos/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Evolução Biológica , Northern Blotting , Southern Blotting , Linhagem Celular , Membrana Celular/metabolismo , Mapeamento Cromossômico , Reagentes de Ligações Cruzadas , DNA/genética , Expressão Gênica , Humanos , Camundongos , Dados de Sequência Molecular , Hibridização de Ácido Nucleico , Plasmídeos , RNA Mensageiro/biossíntese , Ensaio Radioligante , Receptores Imunológicos/biossíntese , Receptores de Interleucina-1RESUMO
The hygromycin phosphotransferase gene was fused in-frame with the herpes simplex virus type 1 thymidine kinase gene. The resulting fusion gene (termed HyTK) confers hygromycin B resistance for dominant positive selection and ganciclovir sensitivity for negative selection and provides a means by which these selectable phenotypes may be expressed and regulated as a single genetic entity.
Assuntos
Clonagem Molecular/métodos , Genes Dominantes , Fosfotransferases (Aceptor do Grupo Álcool) , Fosfotransferases/genética , Seleção Genética , Timidina Quinase/genética , Animais , Sequência de Bases , Linhagem Celular , Citomegalovirus/genética , Ganciclovir/farmacologia , Camundongos , Dados de Sequência Molecular , Iniciação Traducional da Cadeia Peptídica , Plasmídeos , Ratos , Mapeamento por Restrição , Simplexvirus/enzimologia , Simplexvirus/genética , Transdução Genética , TransfecçãoRESUMO
IL-7 cDNA clones were used to isolate clones from the human IL-7 gene locus. Characterization of the clones revealed that the human IL-7 gene contains six exons, distributed over more than 33-kbp. An 18 amino acid insert found in human IL-7, for which no counterpart has yet been demonstrated in murine IL-7, is exactly encoded by exon 5 of the human gene. Clones were also isolated containing 5' flanking sequences and the first four exons of the murine IL-7 gene. RNase protection studies of murine IL-7 mRNA, as well as the sequences of 5'-terminal murine IL-7 cDNA clones obtained by anchored polymerase chain reaction cloning, indicate that the murine IL-7 gene initiates transcription at multiple sites within a 200-bp region. This region, and the sequence upstream of this region, appears to lack transcriptional regulatory sequences commonly found in eukaryotic promoters, including the TATA and CAAT sequences. However, the region lies within a CpG island, and contains potential recognition sequences for the "helix-loop-helix" class of DNA binding proteins.